Covered recipient · General Payments record
JOHN GALGANI
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$26,966.52
- Reported across 335 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,071.34 | 69 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BETA BIONICS, INC. | $324.29 | 5 |
| Ascendis Pharma Inc | $270.54 | 10 |
| SANOFI-AVENTIS U.S. LLC | $205.85 | 3 |
| TOLMAR, INC. | $174.74 | 8 |
| Insulet Corporation | $141.95 | 2 |
| Medtronic, Inc. | $125.00 | 1 |
| ABBVIE INC. | $113.72 | 5 |
| SANOFI PASTEUR INC. | $92.30 | 3 |
| GlaxoSmithKline, LLC. | $86.11 | 4 |
| Corium, Inc. | $64.95 | 5 |
| PFIZER INC. | $64.32 | 3 |
| Azurity Pharmaceuticals, Inc. | $56.43 | 3 |
| Neurocrine BioSciences, Inc. | $47.39 | 2 |
| Xeris Pharmaceuticals, Inc. | $43.49 | 2 |
| Phadia US Inc. | $27.59 | 1 |
| IRONSHORE PHARMACEUTICALS INC. | $23.80 | 1 |
| Tris Pharma Inc | $22.38 | 1 |
| Amphastar Pharmaceuticals, Inc. | $21.96 | 1 |
| Endo Pharmaceuticals Inc. | $21.82 | 1 |
| Novo Nordisk AS | $21.65 | 1 |
| Kyowa Kirin, Inc. | $19.17 | 1 |
| Neurelis, Inc. | $17.80 | 1 |
| Cranial Technologies, Inc | $17.71 | 1 |
| Alexion Pharmaceuticals, Inc. | $17.62 | 1 |
| Merck Sharp & Dohme Corporation | $17.20 | 1 |
| Noven Therapeutics, LLC | $16.64 | 1 |
| Kowa Pharmaceuticals America, Inc. | $14.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (69)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.